Active immunotherapy used alone for maintenance of patients with acute myeloid leukaemia.
D000293:Adolescent; D000328:Adult; D000368:Aged; D001856:Bone Marrow Examination; D003561:Cytarabine / Q000627:therapeutic use; D003630:Daunorubicin / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007114:Immunization; D007167:Immunotherapy; D015470:Leukemia, Myeloid, Acute / Q000276:immunology / Q000628:therapy; D007962:Leukocytes / Q000276:immunology / Q000528:radiation effects; D008297:Male; D008875:Middle Aged; D011830:Radiation Effects; D012008:Recurrence; D012075:Remission, Spontaneous; D013997:Time Factors
D003561:Cytarabine; D003630:Daunorubicin